These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Survival of salivary gland cancer stem cells requires mTOR signaling. Andrade NP; Warner KA; Zhang Z; Pearson AT; Mantesso A; Guimaraēs DM; Altemani A; Mariano FV; Nunes FD; Nör JE Cell Death Dis; 2021 Jan; 12(1):108. PubMed ID: 33479203 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic inhibition of Bmi-1 ablates chemoresistant cancer stem cells in adenoid cystic carcinoma. Sahara S; Warner KA; Herzog AE; Zhang Z; Nör JE Oral Oncol; 2023 Jul; 142():106437. PubMed ID: 37267716 [TBL] [Abstract][Full Text] [Related]
4. p53 Inhibits Bmi-1-driven Self-Renewal and Defines Salivary Gland Cancer Stemness. Rodriguez-Ramirez C; Zhang Z; Warner KA; Herzog AE; Mantesso A; Zhang Z; Yoon E; Wang S; Wicha MS; Nör JE Clin Cancer Res; 2022 Nov; 28(21):4757-4770. PubMed ID: 36048559 [TBL] [Abstract][Full Text] [Related]
5. Sensitizing mucoepidermoid carcinomas to chemotherapy by targeted disruption of cancer stem cells. Guimarães DM; Almeida LO; Martins MD; Warner KA; Silva AR; Vargas PA; Nunes FD; Squarize CH; Nör JE; Castilho RM Oncotarget; 2016 Jul; 7(27):42447-42460. PubMed ID: 27285758 [TBL] [Abstract][Full Text] [Related]
6. Anti-tumor effect of inhibition of IL-6 signaling in mucoepidermoid carcinoma. Mochizuki D; Adams A; Warner KA; Zhang Z; Pearson AT; Misawa K; McLean SA; Wolf GT; Nör JE Oncotarget; 2015 Sep; 6(26):22822-35. PubMed ID: 26287605 [TBL] [Abstract][Full Text] [Related]
7. ALDH/CD44 identifies uniquely tumorigenic cancer stem cells in salivary gland mucoepidermoid carcinomas. Adams A; Warner K; Pearson AT; Zhang Z; Kim HS; Mochizuki D; Basura G; Helman J; Mantesso A; Castilho RM; Wicha MS; Nör JE Oncotarget; 2015 Sep; 6(29):26633-50. PubMed ID: 26449187 [TBL] [Abstract][Full Text] [Related]
8. Cisplatin induces Bmi-1 and enhances the stem cell fraction in head and neck cancer. Nör C; Zhang Z; Warner KA; Bernardi L; Visioli F; Helman JI; Roesler R; Nör JE Neoplasia; 2014 Feb; 16(2):137-46. PubMed ID: 24709421 [TBL] [Abstract][Full Text] [Related]
9. Salivary Gland Cancer Patient-Derived Xenografts Enable Characterization of Cancer Stem Cells and New Gene Events Associated with Tumor Progression. Keysar SB; Eagles JR; Miller B; Jackson BC; Chowdhury FN; Reisinger J; Chimed TS; Le PN; Morton JJ; Somerset HL; Varella-Garcia M; Tan AC; Song JI; Bowles DW; Reyland ME; Jimeno A Clin Cancer Res; 2018 Jun; 24(12):2935-2943. PubMed ID: 29555661 [No Abstract] [Full Text] [Related]
10. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2. Keysar SB; Le PN; Miller B; Jackson BC; Eagles JR; Nieto C; Kim J; Tang B; Glogowska MJ; Morton JJ; Padilla-Just N; Gomez K; Warnock E; Reisinger J; Arcaroli JJ; Messersmith WA; Wakefield LM; Gao D; Tan AC; Serracino H; Vasiliou V; Roop DR; Wang XJ; Jimeno A J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27634934 [TBL] [Abstract][Full Text] [Related]
11. Prognostic Significance of Cancer Stem Cell Markers in Patients With Salivary Gland Carcinomas. Sadeghi H; Saffar H; Taheri P; Yazdani F; Etebarian A Appl Immunohistochem Mol Morphol; 2022 Apr; 30(4):284-290. PubMed ID: 35001035 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression. Deng J; Bai X; Feng X; Ni J; Beretov J; Graham P; Li Y BMC Cancer; 2019 Jun; 19(1):618. PubMed ID: 31234823 [TBL] [Abstract][Full Text] [Related]
13. Dual-Blocking of PI3K and mTOR Improves Chemotherapeutic Effects on SW620 Human Colorectal Cancer Stem Cells by Inducing Differentiation. Kim MJ; Koo JE; Han GY; Kim B; Lee YS; Ahn C; Kim CW J Korean Med Sci; 2016 Mar; 31(3):360-70. PubMed ID: 26955235 [TBL] [Abstract][Full Text] [Related]
14. Synergistic efficacy of combined EGFR and HDAC inhibitors overcomes tolerance to EGFR monotherapy in salivary mucoepidermoid carcinoma. Parag-Sharma K; Tasoulas J; Musicant AM; do Nascimento-Filho CHV; Zhu Z; Twomey C; Liu P; Castilho RM; Amelio AL Oral Oncol; 2021 Apr; 115():105166. PubMed ID: 33581505 [TBL] [Abstract][Full Text] [Related]
15. Association between high expression of phosphorylated Akt and mammalian target of rapamycin and improved survival in salivary gland adenoid cystic carcinoma. Ouyang DQ; Liang LZ; Ke ZF; Zheng GS; Weng DS; Yang WF; Su YX; Liao GQ Head Neck; 2017 Jun; 39(6):1145-1154. PubMed ID: 28230926 [TBL] [Abstract][Full Text] [Related]
16. Embryonic stem cells markers Oct4 and Nanog correlate with perineural invasion in human salivary gland mucoepidermoid carcinoma. Destro Rodrigues MF; Sedassari BT; Esteves CM; de Andrade NP; Altemani A; de Sousa SC; Nunes FD J Oral Pathol Med; 2017 Feb; 46(2):112-120. PubMed ID: 27131799 [TBL] [Abstract][Full Text] [Related]
17. The IL-6R and Bmi-1 axis controls self-renewal and chemoresistance of head and neck cancer stem cells. Herzog AE; Warner KA; Zhang Z; Bellile E; Bhagat MA; Castilho RM; Wolf GT; Polverini PJ; Pearson AT; Nör JE Cell Death Dis; 2021 Oct; 12(11):988. PubMed ID: 34689150 [TBL] [Abstract][Full Text] [Related]
18. Targeting Notch and EGFR signaling in human mucoepidermoid carcinoma. Ni W; Chen Z; Zhou X; Yang R; Yu M; Lu J; Kaye FJ; Wu L Signal Transduct Target Ther; 2021 Jan; 6(1):27. PubMed ID: 33473104 [TBL] [Abstract][Full Text] [Related]
19. Targeting cancer stem cells in glioblastoma multiforme using mTOR inhibitors and the differentiating agent all-trans retinoic acid. Friedman MD; Jeevan DS; Tobias M; Murali R; Jhanwar-Uniyal M Oncol Rep; 2013 Oct; 30(4):1645-50. PubMed ID: 23877261 [TBL] [Abstract][Full Text] [Related]
20. FGFR signaling regulates resistance of head and neck cancer stem cells to cisplatin. McDermott SC; Rodriguez-Ramirez C; McDermott SP; Wicha MS; Nör JE Oncotarget; 2018 May; 9(38):25148-25165. PubMed ID: 29861860 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]